“…3,7,20,22,23,27,29,36,59,65,77,82 Accordingly, detecting PKA-II activity with conformation-specific antibodies in rodent or iPSCderived nociceptors allows to monitor PKA-mediated sensitization stimuli as well as desensitizing opioid activity. 6,7,[29][30][31][32][33][34][35]78 Protocols to generate human nociceptors from human pluripotent stem cells (PSCs) have been developed based on small-molecule treatment, transcription factor overexpression, or combinations of both. 4,12,28,41,42,51,55,63,66,75 Such iPSC-derived nociceptors reflect a large range of nociceptive properties and have been used successfully to model neuropathic pain phenotypes in vitro.…”